Neelam Goyal, MD / Gil I. Wolfe, MD, FAAN - Spotlight on Seronegative Generalized Myasthenia Gravis: From Clinical Uncertainty to Personalized Treatment
About this episode
The episode discusses Seronegative Generalized Myasthenia Gravis and the transition from clinical uncertainty to personalized treatment.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/WNQ865. CME credit will be available until June 29, 2027. Spotlight on Seronegative Generalized Myasthenia Gravis: From Clinical Uncertainty to Personalized Treatment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an educational grant from argenx US, Inc. Disclosure information is available at the beginning of the video presentation.
People in this episode
Guests: Neelam Goyal, MD, Gil I. Wolfe, MD, FAAN
Topics covered
- Seronegative Generalized Myasthenia Gravis
- Personalized Treatment
- Clinical Uncertainty
- Healthcare Education
- Continuing Medical Education
Keywords
- Myasthenia Gravis
- CME
- healthcare professionals
- patient care
- clinical treatment
Sponsors
argenx US, Inc.
Mentioned in this episode
Organizations: PeerView Institute for Medical Education, Accreditation Council for Continuing Medical Education, Accreditation Council for Pharmacy Education, American Nurses Credentialing Center
More episodes of PeerView Immunology & Transplantation CME/CNE/CPE Audio Podcast
- Philip J. Mease, MD, MACR - Breaking the Burden of Systemic Lupus Erythematosus: Patient Testimonials and Interprofessional Perspectives on New Developments With CAR-T Cell Therapy
- Jiwon Oh, MD, PhD, FRCPC, Gregory F. Wu, MD, PhD, FAAN - New Pathways, New Possibilities in Multiple Sclerosis: BTK Inhibition and the Future of Patient Care
Explore listener stats, chart rankings, contacts and more on the PeerView Immunology & Transplantation CME/CNE/CPE Audio Podcast podcast page.